Novel approach in primary care setting may help identify patients with COPD

October 28, 2016
Simple test may help PCPs diagnose COPD early on. Credit: ATS

With five simple questions and an inexpensive peak expiratory flow (PEF) meter, primary care clinicians may be able to diagnose many more patients with chronic obstructive pulmonary disease, or COPD, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. Follow-up studies will help establish if earlier identification and treatment of people with COPD improves quality of life and health outcomes.

According to the National Heart, Lung, and Blood Institute, more than 12 million Americans are diagnosed with COPD, the third leading cause of death in the country. It is estimated that another 12 million have the disease but have not been diagnosed.

"The researchers created and tested a simple tool that may help practitioners improve care by finding people who have COPD but didn't know it," said Dr. James Kiley, director of the Division of Lung Diseases at NHLBI. "The hope is that by finding individuals with COPD at an earlier stage of illness, we might be able to offer them treatments which can improve their disease. NHLBI's support of the research that led to this tool exemplifies the ongoing commitment of NHLBI to COPD research."

In "A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease," lead author Fernando J. Martinez, MD, MS, chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medical College, and colleagues report results of a novel method they developed. It is intended for use in a setting to help identify "patients with COPD of a severity significant enough to justify therapy with currently available agents."

In the first step, patients complete a COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURETM). Written at a sixth-grade level, these five questions assess smoke and pollution exposure, breathing problems, how easily the patient tires and number of acute respiratory illnesses.

Those whose answers indicate they are at high risk for COPD symptoms and/or exacerbations are referred directly for definitive diagnostic tests. Those whose answers indicate minimal risk symptoms and/or exacerbations need no further testing.

Patients whose answers put them in the middle range for risk perform a simple PEF test during their visit. Men who exhale less than 350 liters/minute and women who exhale less than 250 liters/minute are referred for definitive testing.

In their case-control study of 346 men and women (average age 63), researchers found that 52 percent of subjects required PEF to determine if further diagnostic testing was required.

The authors report that the questionnaire plus PEF had a high rate of sensitivity (89.7 percent) and specificity (78.1 percent) for cases versus controls, including those with mild COPD. The sensitivity was similar, but the specificity rose to 93.1 percent when cases were compared to non-COPD controls.

Dr. Martinez attributes the promising results of this initial study to input from both patients and primary care collaborators from the beginning of the development process. "Primary care clinicians were emphatic: it could not be a long and complicated questionnaire, and we could not include complex pulmonary function testing upfront," he said.

From 44 possible questions, patients who were living with COPD, recently diagnosed, or considered at risk of developing the disease helped researchers select the five best questions and provided key insights into their wording. The five final questions are:

  1. Have your ever lived or worked in a place with dirty or polluted air, smoke, second-hand smoke or dust?
  2. Does your breathing change with seasons, weather, or air quality?
  3. Does your breathing make it difficult to do things such as carry heavy loads, shovel dirt or snow, jog, play tennis, or swim?
  4. Compared to others your age, do you tire easily?
  5. In the past 12 months, how many times did you miss work, school, or other activities due to a cold, bronchitis, or pneumonia?

"We as clinicians did not expect some of the questions to be included, but they resonated with patients," Dr. Martinez said, noting in particular the second and fourth questions. Dr. Martinez added that the first question, one of many included to assess inhalational exposures, did not directly ask about smoking history, and was "less pejorative and identified potentially more exposures."

The authors emphasize the approach is case-finding, rather than diagnostic or screening, and before CAPTURETM plus PEF can be recommended widely, it must be validated in a large prospective study across a broad range of primary care settings. They have proposed such a study that includes approximately 5,000 patients across 75 primary care sites to determine if CAPTURE improves COPD diagnosis, facilitates primary clinician experience and, most importantly, improves COPD care and the quality of life for patients.

Explore further: COPD diagnosis study finds spirometry underused, misdiagnosis common

Related Stories

COPD diagnosis study finds spirometry underused, misdiagnosis common

October 18, 2016
According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in ...

Considerable health care system burden for undiagnosed COPD

August 15, 2016
(HealthDay)—The overall health system burden of exacerbations in patients with undiagnosed chronic obstructive pulmonary disease (COPD) is considerable, according to a study published in the Aug. 1 issue of the American ...

Novel tool can identify COPD

September 29, 2015
A novel approach for the identification of chronic obstructive pulmonary disease (COPD) has been developed by a team of researchers in the USA.

Simple screening tool helps determine COPD risk

June 29, 2016
A simple 7-item screening tool can help clinicians identify patients at risk for chronic obstructive pulmonary disease (COPD), even if they are not experiencing any symptoms.

COPD exacerbations lead to lung function decline, particularly among those with mild COPD

September 8, 2016
Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the American Thoracic Society's ...

Exacerbations of COPD accelerate lung-function loss

May 17, 2016
Exacerbations of chronic obstructive pulmonary disease (COPD) accelerate the loss of lung function especially among patients with mild disease, according to researchers at National Jewish Health and other institutions. Barry ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.